Delivery Order SPE2DB24D2101-SPE2DB25FKNYM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,650.39 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of August 26, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Provocholine Inhalation Solution in 18ML packs, with a contract ceiling value of $11,511.90. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ml pack quantities, with a ceiling value of $2,210. The contract, awarded on September 8, 2025, represents a firm fixed-price delivery order with a completion deadline of September 9, 2025. This award utilizes no set-aside designation and is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $5,501.30 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order is a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Provocholine Inhalation Solution Pack (18ML) with a ceiling value of $1,100.26 under a firm fixed-price contract type. This award, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $7,538.38 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 17, 2025, for Provocholine inhalation solution in 18-milliliter packs. The contract is set to be completed by September 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. This delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Provocholine 100 mg vials, valued at $27,352.78. The award is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. The ultimate completion date is set for September 3, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a $2,200.52 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML pack quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Provocholine 100 mg vials, with a ceiling value of $1,895.08 and a firm fixed price structure. This non-set-aside, competitively awarded contract is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's...
- This delivery order, awarded on July 23, 2025, procures Provocholine inhalation solution in 18ML pack quantities for the Defense Department's Medical Supply Chain with a ceiling value of $6,732.76. The award is issued under firm fixed pricing with an ultimate completion date of July 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was selected as the awardee through competitive procurement with no set-aside designation. This delivery order is issued as a...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNYMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Provocholine inhalation solution in 18ML packs under a firm fixed-price contract with a ceiling value of $1,804.77. This non-competitive delivery order is set to conclude on August 28, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Provocholine is a bronchial challenge agent used in pulmonary function testing to assess airway responsiveness, making this a specialized pharmaceutical procurement for military healthcare applications. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal medical supply needs, AmerisourceBergen maintains an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains for military and veteran healthcare systems. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply specialty medications, vaccines, and medical commodities to defense healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/27/25 |